You’re looking at two fish oil supplements. One has 600mg EPA and 200mg DHA. The other has 200mg EPA and 500mg DHA. Both are marketed as “omega-3 supplements,” both claim to support brain and heart health, and neither label explains why these numbers are so different — or which one is right for you.
This is one of the most practical and most underexplained questions in the supplement space. EPA and DHA are both omega-3 fatty acids, both found in fish, and both genuinely useful. But they work through entirely different mechanisms in the body, which means they’re not interchangeable — and choosing between them, or between different ratios of them, isn’t arbitrary.
This guide explains the fundamental difference between EPA and DHA at a mechanistic level, covers what each one is best suited for, and gives you a framework for choosing the right ratio based on your actual goals.
Key Takeaways
- EPA (eicosapentaenoic acid) is primarily a signaling molecule. It’s converted into eicosanoids and resolvins — compounds that regulate inflammation, platelet activity, and immune responses. Its effects are dynamic and relatively fast-acting.
- DHA (docosahexaenoic acid) is primarily a structural molecule. It’s incorporated into cell membrane phospholipids throughout the body — especially in the brain, retina, and nervous system. Its effects are cumulative and foundational.
- For mood, anxiety, and inflammation: EPA-predominant formulations (>60% EPA) show stronger clinical effects. A 2019 meta-analysis of 26 trials found EPA-dominant supplements significantly outperformed DHA-dominant ones for depressive symptoms.
- For brain development, eye health, and cognitive aging: DHA is the critical fatty acid — it comprises 97% of the omega-3 content in the brain and is the dominant structural omega-3 in the retina.
- For pregnancy: DHA is the priority. The fetal brain and retina accumulate DHA rapidly during the third trimester, drawing from maternal stores.
- Standard fish oil (typically 180mg EPA / 120mg DHA, a 3:2 EPA:DHA ratio) provides a reasonable general maintenance balance — the EPA:DHA ratio matters most when you’re targeting a specific outcome.
The Fundamental Difference: Signaling vs. Structure
This distinction is the key to understanding everything else in this guide.
EPA acts primarily as a precursor to signaling compounds. When your body processes EPA, it produces eicosanoids (prostaglandins, leukotrienes, thromboxanes) and, more recently discovered, specialized pro-resolving mediators called resolvins. These molecules regulate inflammation — EPA-derived eicosanoids are significantly less pro-inflammatory than those derived from arachidonic acid (an omega-6 fatty acid), so higher EPA levels shift the body’s inflammatory signaling balance in an anti-inflammatory direction. EPA also competes with arachidonic acid for the same enzymes, which means more EPA in the diet directly reduces the production of the more inflammatory omega-6-derived compounds.
This is why EPA’s effects tend to be relatively measurable: you can see changes in inflammatory markers, mood assessments, and triglyceride levels within weeks.
DHA acts primarily as a structural component of cell membranes. DHA’s molecular structure — 22 carbons with 6 double bonds — makes it the most unsaturated fatty acid found in large quantities in the body. This extreme flexibility gives DHA-rich membranes exceptional fluidity, which is critical for cells that need to respond rapidly or transmit signals efficiently: neurons, photoreceptors in the retina, sperm cells.
When DHA is embedded in cell membranes, it influences how membrane proteins (including neurotransmitter receptors and ion channels) function — simply by affecting the physical properties of the membrane around them. Higher DHA content in neuronal membranes is associated with faster synaptic signaling, better receptor function, and more efficient neurotransmitter release and uptake.
This structural role is why DHA’s effects are more foundational and harder to measure acutely: you’re not changing a signaling pathway, you’re gradually changing the physical architecture of your cells.
What Is DHA Omega-3 and Why Is It in the Brain?
DHA makes up approximately 97% of the omega-3 fatty acid content in the brain and about 93% of the omega-3 content in the retina. These numbers raise an obvious question: why has the body chosen to concentrate so much DHA specifically in neural tissue?
The answer is membrane fluidity. Neural function depends on cells that can change state rapidly — neurons fire, recover, and fire again thousands of times per second; photoreceptors need to respond to single photons of light within milliseconds. This requires cell membranes that are highly responsive and fluid. DHA’s six double bonds create a highly flexible molecular structure that keeps membranes fluid even at body temperature, enabling the rapid conformational changes that ion channels and receptors need to function.
As DHA levels in neural tissue decline — whether through inadequate dietary intake, aging, or both — membrane fluidity decreases. This isn’t a dramatic failure; it’s a gradual degradation of cellular responsiveness that shows up as slower processing speed, reduced working memory, or the cognitive changes associated with aging. Supplementing DHA doesn’t create new neurons; it provides the raw material for maintaining the structural integrity of existing ones.
DHA is also involved in brain protection. It’s a precursor to neuroprotectins — molecules that reduce oxidative stress and inflammatory damage in neural tissue. This is distinct from EPA’s anti-inflammatory role and more specifically relevant to neuroprotection.
EPA vs. DHA for Depression and Anxiety
This is one of the most well-studied distinctions between the two fatty acids, and the evidence is clear enough to give practical guidance.
For depression, EPA has the stronger evidence. A 2019 meta-analysis published in Translational Psychiatry (Liao et al.) analyzed 26 randomized controlled trials and found that omega-3 supplementation produced statistically significant improvements in depressive symptoms — but the effect was significantly larger in formulations where EPA comprised more than 60% of the total omega-3 content. DHA-dominant formulations did not show the same benefit.
The mechanism likely involves several pathways: EPA’s anti-inflammatory effects reduce neuroinflammation, which is increasingly recognized as a factor in depressive disorders. EPA also influences serotonin and dopamine receptor availability through its effects on cell membrane composition in neuronal synapses.
For anxiety, the evidence points in the same direction. A 2018 meta-analysis in JAMA Network Open found significant reductions in anxiety symptoms with omega-3 supplementation at doses ≥2 grams/day, with EPA-predominant formulations showing stronger effects.
What this means practically: If mood support is a primary goal, look for a supplement where EPA significantly predominates — ideally EPA comprising 60% or more of the total EPA+DHA content. Pure EPA supplements (like prescription Vascepa) or high-EPA fish oil concentrates are the most targeted options. Standard fish oil (3:2 EPA:DHA ratio) is reasonable, but less targeted for this specific goal.
EPA vs. DHA for Brain Health and Cognitive Function
Here the picture is more nuanced — and the DHA role becomes more prominent.
For structural brain health and cognitive aging: DHA is the critical fatty acid. The brain’s DHA content declines gradually with age, and this decline correlates with cognitive performance. Multiple studies have found associations between higher DHA status and larger brain volume, better memory performance, and slower cognitive decline in older adults. Intervention trials using DHA supplementation in people with age-related cognitive decline have shown improvements in episodic memory and processing speed.
For acute mood effects in the context of cognitive health: EPA contributes here too, primarily through neuroinflammation reduction.
The distinction is timeline and mechanism:
- DHA supports the physical architecture of the brain — maintenance and structural integrity, most relevant over the long term and during development
- EPA modulates the brain’s inflammatory and signaling environment — effects that are more acute and more measurable in shorter intervention windows
For someone managing cognitive aging concerns, a balanced approach covering both is logical — but ensuring adequate DHA specifically is the more foundational priority.
DHA in Pregnancy: Why It’s Non-Negotiable
DHA is actively transported across the placenta during pregnancy, with the highest transfer rates occurring during the third trimester — exactly when fetal brain and retinal development is most rapid. The fetus accumulates DHA in neural and retinal tissue at rates that can significantly draw down maternal stores if dietary intake is inadequate.
Studies of infants born to mothers with higher DHA status consistently show better outcomes in visual acuity, problem-solving, hand-eye coordination, and language development in the first years of life. A 2019 meta-analysis found that maternal DHA supplementation significantly improved infant DHA status at birth and was associated with better neurodevelopmental outcomes.
The practical recommendation: The European Commission recommends 200 mg DHA/day above normal intake during pregnancy and lactation. Many prenatal supplements now include DHA, but the amounts vary — check the label. For women who don’t regularly eat fatty fish, algal oil (the vegan/vegetarian DHA source) is molecularly equivalent to fish-derived DHA and an appropriate alternative.
On EPA during pregnancy: EPA is also transferred to the fetus but at lower rates than DHA. Both fatty acids are beneficial during pregnancy; DHA is the one with more specific developmental relevance, which is why DHA-focused prenatal omega-3 supplements are more common than EPA-focused ones.
EPA and DHA Ratio: What to Look for and Why It Matters
This is the question most omega-3 articles don’t answer, and it’s the most practically useful one: what ratio of EPA to DHA should you choose?
Standard fish oil (typically 180mg EPA / 120mg DHA = 3:2 ratio): The most commonly available form. This ratio reflects the natural composition of fish tissue fairly well. It provides a reasonable balance of EPA’s signaling benefits and DHA’s structural benefits. For general health maintenance — when you don’t have a specific targeted goal — standard fish oil is a sensible default.
High-EPA formulations (EPA:DHA ratio of 2:1 or higher, sometimes pure EPA): Best suited for mood support, anxiety, and anti-inflammatory purposes. Look for supplements where the EPA content is at least double the DHA content. Prescription EPA (icosapentaenoic acid) is the most targeted form for triglyceride reduction and cardiovascular risk in people with elevated triglycerides.
High-DHA formulations (DHA:EPA ratio of 2:1 or higher): Best suited for brain health in aging adults, cognitive support, and eye health. Also the appropriate focus during pregnancy and breastfeeding.
Combined DHA+EPA balanced formulations: For people who want comprehensive coverage — particularly if both mood support and brain/eye health are goals — a balanced formulation covering both in meaningful amounts works well.
Reading the Label
The numbers that matter are the specific EPA and DHA amounts listed under the supplement facts, not the total fish oil or omega-3 weight on the front of the bottle. A “1000mg fish oil” capsule might contain 180mg EPA + 120mg DHA (300mg total omega-3) — the remaining 700mg is other fats that aren’t omega-3. Always check the Supplement Facts panel for the specific EPA and DHA milligrams per serving.
How Much EPA and DHA Per Day? A Practical Guide
There’s no official RDA for EPA or DHA specifically (the NIH’s Adequate Intake applies to ALA only). Clinical practice and research provide useful reference points:
For general health maintenance: 500 mg/day combined EPA+DHA is a commonly cited minimum for cardiovascular benefit and general omega-3 support. Standard fish oil (1–2 capsules of a typical 1000mg product) typically provides 300–600 mg combined EPA+DHA.
For mood and anxiety support: The clinical trials showing significant effects used 1–2 grams/day of EPA specifically, often in high-EPA formulations. Standard fish oil at 1–2 capsules/day may not reach this threshold for EPA alone.
For triglyceride reduction: 2–4 grams/day combined EPA+DHA (prescription-strength or high-dose supplements) is the documented effective range. This requires more than standard OTC dosing.
For pregnancy and breastfeeding: 200mg DHA/day above normal intake is the European Commission recommendation. Many women will need a dedicated DHA supplement or a prenatal with specified DHA content to reach this.
For cognitive support in aging adults: Most trials used 1–2 grams/day DHA, sometimes with EPA. Higher doses have been studied in cognitive impairment contexts.
The consistent finding across studies: more is generally more effective up to a point, but the dose needs to be matched to the goal. A standard OTC fish oil capsule is a starting point, not necessarily a therapeutic dose for specific outcomes.
EPA and DHA: Do You Need Both?
The short answer: yes, both contribute meaningfully, and most people benefit from both — but the ratio matters based on your priorities.
The body can convert EPA to DHA, but the conversion rate is very limited. DHA can be retro-converted to EPA, but again at low rates. In practice, the forms you consume are largely what you get — meaning choosing between EPA-predominant and DHA-predominant supplements has real implications for which biological functions you’re supporting most.
For people with a single clear goal (mood support → EPA-predominant; pregnancy → DHA-predominant; aging brain → DHA-predominant), a targeted ratio makes sense. For people supplementing for general wellness with no specific priority, a balanced EPA+DHA formulation — or simply eating fatty fish twice weekly — covers both pathways reasonably well.
What to Do If Your Current Supplement Doesn’t Match Your Goals
You’re already taking fish oil. You look at the label and realize the ratio or dose doesn’t align with what you’re now trying to support. Here’s how to approach it:
If you need more EPA (for mood/inflammation): Add a high-EPA concentrate on top of your current supplement, or switch to one where EPA is clearly the dominant component. Products labeled “EPA-dominant” or “ultra EPA” typically have EPA:DHA ratios of 3:1 or higher.
If you need more DHA (for brain/eyes/pregnancy): Look for supplements specifically formulated for cognitive support or prenatal use — these tend to favor DHA. Algal oil is often DHA-dominant and appropriate for vegans and vegetarians.
If you’re getting adequate EPA and DHA from diet: Two servings per week of fatty fish (salmon, mackerel, sardines) provides approximately 1.5–2 grams combined EPA+DHA — meaningful enough that supplementation may be more about filling specific gaps than complete replacement.
Frequently Asked Questions
What is the difference between EPA and DHA? EPA (eicosapentaenoic acid) is primarily a signaling molecule — it produces eicosanoids and resolvins that regulate inflammation, mood, and immune responses. DHA (docosahexaenoic acid) is primarily a structural molecule — it’s incorporated into cell membranes throughout the body, particularly in the brain and retina, where it maintains membrane fluidity and supports cellular function. Both are omega-3 fatty acids found in fatty fish and fish oil, but their functions in the body are meaningfully different.
Which is better for the brain: EPA or DHA? For structural brain health and cognitive aging, DHA is more critical — it comprises 97% of the brain’s omega-3 content and is the dominant fatty acid in neuronal cell membranes. For mood and neuroinflammation (which affects brain function), EPA has stronger clinical evidence. Both contribute to brain health, through different mechanisms, making a balanced approach reasonable for most people.
Should I take EPA or DHA for depression? The clinical evidence favors EPA-predominant formulations for depression. A 2019 meta-analysis of 26 trials found that supplements with EPA comprising >60% of total omega-3 content produced significantly greater improvements in depressive symptoms than DHA-predominant formulations. Look for high-EPA fish oil or concentrated EPA supplements if this is a primary goal.
What is the best EPA to DHA ratio? For general health: standard fish oil (approximately 3:2 EPA:DHA) is a reasonable baseline. For mood and anti-inflammatory purposes: 2:1 or higher EPA:DHA. For brain health, cognitive aging, and eye health: DHA-predominant ratios. For pregnancy: DHA-predominant (DHA is the developmental priority). The “best” ratio depends on your goal.
How much EPA and DHA do I need per day? For general maintenance: 500mg combined EPA+DHA daily. For mood support: 1–2g EPA specifically. For triglyceride reduction: 2–4g combined EPA+DHA. For pregnancy: 200mg DHA above normal intake. Always check the specific EPA and DHA amounts in the Supplement Facts panel, not just the total fish oil weight.
Can I take EPA and DHA together? Yes — most fish oil supplements contain both, and there’s no interaction between them. Taking them together means you’re supporting both the signaling and structural roles of omega-3s simultaneously. The question is which ratio serves your goals better, not whether to combine them at all.
The Bottom Line
EPA and DHA aren’t competing supplements — they’re complementary fatty acids with different primary roles. EPA runs the inflammatory and mood-signaling systems. DHA builds and maintains the physical architecture of neural tissue. Both matter; the ratio between them matters when you have a specific goal.
For most people who aren’t targeting a specific outcome: standard fish oil covering both, or fatty fish twice weekly, provides a reasonable baseline. For mood and anxiety support: EPA-predominant. For brain aging, eye health, and pregnancy: DHA-predominant. For triglycerides: high combined dose with EPA emphasis.
The label on your current supplement tells you what you’re getting. The research tells you what that serves best.
Want to understand the differences between fish oil, krill oil, and algae oil — including which delivers EPA and DHA most efficiently? Fish Oil vs. Krill Oil vs. Algae Oil: How to Choose (C4)
Not sure if you’re getting enough omega-3 overall? See how to assess your intake and the signs of inadequacy: Omega-3 Deficiency Symptoms: Signs Your Body May Not Be Getting Enough (C1)
References
- National Institutes of Health Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. Updated May 2026. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
- Liao Y, Xie B, Zhang H, et al. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. 2019;9(1):190. doi:10.1038/s41398-019-0515-5
- Su KP, Tseng PT, Lin PY, et al. Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms. JAMA Network Open. 2018;1(5):e182327. doi:10.1001/jamanetworkopen.2018.2327
- Dyall SC. Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience. 2015;7:52. doi:10.3389/fnagi.2015.00052
- Devarshi PP, Grant RW, Ikonte CJ, Hazels Mitmesser S. Maternal omega-3 nutrition, placental transfer and fetal brain development in gestational diabetes and preeclampsia. Nutrients. 2019;11(5):1107. doi:10.3390/nu11051107
- Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions. 2017;45(5):1105-1115. doi:10.1042/BST20160474